Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/Phase 3 trial evaluating Gyntima Balance to prevent recurrences of bacterial vaginosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gyntima Balance

Snippet

Sponsor: Kaneka Americas Holding Inc. | Conditions: Vaginosis, Bacterial, Bacterial Vaginosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING